ClinicalTrials.Veeva

Menu

Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy

A

Aswan University Hospital

Status

Unknown

Conditions

Postmenopausal Bleeding

Treatments

Drug: dinoprostone
Drug: INH

Study type

Interventional

Funder types

Other

Identifiers

NCT04500496
aswu/351/4/19

Details and patient eligibility

About

To compare the effectiveness of vaginal dinoprostone and vaginal Isonicotinic acid hydrazide in minimizing the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.

Full description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.

Enrollment

200 estimated patients

Sex

Female

Ages

45 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Menopausal patients with an indication for office hysteroscopy (postmenopausal bleeding or abnormal ultrasound findings)

Exclusion criteria

  • Nulliparous patients
  • patients with cervical pathology
  • retroverted uterus (detected by transvaginal ultrasound)
  • previous cervical surgery
  • patients with severe vaginal bleeding
  • allergy or contraindications to dinoprostone or INH therapy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

INH
Experimental group
Description:
3 tablet of INH 900 mg inserted by the patient 12 hours before the scheduled office hysteroscopy.
Treatment:
Drug: INH
dinoprostone
Active Comparator group
Description:
1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the patient 12 hours before the scheduled office hysteroscopy.
Treatment:
Drug: dinoprostone

Trial contacts and locations

1

Loading...

Central trial contact

hany f Sallam, md; nahla w Shady, md

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems